Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Paying user area
Try for free
HCA Healthcare Inc. pages available for free this week:
- Statement of Comprehensive Income
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Balance Sheet: Assets
- Analysis of Reportable Segments
- Common Stock Valuation Ratios
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Net Profit Margin since 2011
- Return on Assets (ROA) since 2011
- Total Asset Turnover since 2011
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to HCA Healthcare Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Long-term Activity Ratios (Summary)
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).
The analysis of the quarterly financial data reveals several notable trends across the periods under review.
- Net Fixed Asset Turnover
- This ratio exhibits a gradual decline starting from 2.44 in March 2017, reaching a low point around 2.17 in June 2020. Subsequently, a modest recovery is observed, with the ratio rising to 2.46 by December 2021 and maintaining stability at this level through March 2022. The pattern indicates a period of decreasing efficiency in using fixed assets to generate revenue, followed by a gradual improvement in asset utilization efficiency towards the end of the period.
- Net Fixed Asset Turnover (Including Operating Lease, Right-of-Use Asset)
- When incorporating operating leases and right-of-use assets, the turnover ratio similarly trends downward from 2.44 in early 2017 to approximately 2.01 in June 2020. A recovery trend follows, with the ratio increasing to 2.27 by the first quarter of 2022. Notably, this ratio consistently remains lower than the standard net fixed asset turnover, reflecting the impact of lease capitalization on asset base measurements and subsequent asset efficiency ratios.
- Total Asset Turnover
- The total asset turnover ratio remains relatively stable in the initial periods, fluctuating slightly around 1.19–1.21 until late 2018. From 2019 onward, the ratio shows a declining tendency, dropping to a low of 1.00 in June 2020. This decline may suggest reduced efficiency in generating revenue from total assets, possibly influenced by external factors during this timeframe. After mid-2020, the ratio improves gradually, reaching 1.16 by March 2022, though it does not return to earlier peak levels.
- Equity Turnover
- The equity turnover data is sparse, with significant values only reported in June 2021 (213.15) and March 2021 (90.09). The limited data points and large disparity between these figures hinder a clear trend analysis. The unusually high ratios may indicate specific transactional or accounting events influencing equity turnover in these quarters rather than steady operational performance.
Overall, the period from 2017 to early 2022 is characterized by a dip in asset efficiency ratios primarily around mid-2020, followed by a recovery phase. The trends suggest an impact likely linked to broader economic and operational disruptions, with improvements underway towards the later quarters. The incorporation of lease assets affects the net fixed asset turnover, lowering its values but following a similar trend pattern. Total asset turnover reflects moderately lower utilization efficiency in the middle of the period with gradual recovery thereafter.
Net Fixed Asset Turnover
Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||||
Property and equipment, net | ||||||||||||||||||||||||||||
Long-term Activity Ratio | ||||||||||||||||||||||||||||
Net fixed asset turnover1 | ||||||||||||||||||||||||||||
Benchmarks | ||||||||||||||||||||||||||||
Net Fixed Asset Turnover, Competitors2 | ||||||||||||||||||||||||||||
Abbott Laboratories | ||||||||||||||||||||||||||||
CVS Health Corp. | ||||||||||||||||||||||||||||
Elevance Health Inc. | ||||||||||||||||||||||||||||
Intuitive Surgical Inc. | ||||||||||||||||||||||||||||
Medtronic PLC | ||||||||||||||||||||||||||||
UnitedHealth Group Inc. |
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).
1 Q1 2022 Calculation
Net fixed asset turnover
= (RevenuesQ1 2022
+ RevenuesQ4 2021
+ RevenuesQ3 2021
+ RevenuesQ2 2021)
÷ Property and equipment, net
= ( + + + )
÷ =
2 Click competitor name to see calculations.
The financial data reveals several notable trends concerning revenues, property and equipment, net values, and net fixed asset turnover ratios over the period analyzed.
- Revenues
- Revenues exhibit a generally upward trajectory from March 2017 through March 2022, with periodic fluctuations. The value rose from approximately 10,623 million USD in the first quarter of 2017 to a peak near 15,276 million USD in the December 2021 quarter. Notable dips occurred during the 2020 period, especially in the second quarter, likely reflecting external disruptions. Despite this mid-period decline, revenues rebounded strongly in subsequent quarters, approaching prior highs by early 2022.
- Property and Equipment, Net
- The net property and equipment value increased steadily over the entire period. Beginning at approximately 16,462 million USD at the start of 2017, it grew to 24,228 million USD by March 2022. This steady capital investment or asset appreciation suggests an ongoing expansion or upgrading of fixed assets, with no significant reductions or impairments evident. Growth appears consistent without abrupt changes.
- Net Fixed Asset Turnover
- The ratio of net fixed asset turnover remained relatively stable, fluctuating narrowly within a range approximating 2.17 to 2.46 across the periods it was reported. Starting near 2.44 in late 2017, it fell slightly toward mid-2020 at 2.17, correlating with the revenue decline during that time, and subsequently recovered to around 2.46 by early 2022. This pattern indicates that asset utilization efficiency was somewhat affected during the mid-period downturn but recovered thereafter, suggesting improvement in generating revenues from fixed assets towards the end of the timeline.
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)
HCA Healthcare Inc., net fixed asset turnover (including operating lease, right-of-use asset) calculation (quarterly data)
Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||||
Property and equipment, net | ||||||||||||||||||||||||||||
Right-of-use operating lease assets | ||||||||||||||||||||||||||||
Property and equipment, net (including operating lease, right-of-use asset) | ||||||||||||||||||||||||||||
Long-term Activity Ratio | ||||||||||||||||||||||||||||
Net fixed asset turnover (including operating lease, right-of-use asset)1 | ||||||||||||||||||||||||||||
Benchmarks | ||||||||||||||||||||||||||||
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Competitors2 | ||||||||||||||||||||||||||||
CVS Health Corp. |
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).
1 Q1 2022 Calculation
Net fixed asset turnover (including operating lease, right-of-use asset)
= (RevenuesQ1 2022
+ RevenuesQ4 2021
+ RevenuesQ3 2021
+ RevenuesQ2 2021)
÷ Property and equipment, net (including operating lease, right-of-use asset)
= ( + + + )
÷ =
2 Click competitor name to see calculations.
The revenues exhibit an overall upward trend from March 31, 2017, through March 31, 2022, with some volatility observed during the period from March 31, 2020, to June 30, 2020, which corresponds with a notable dip. This decline is temporarily reversed in subsequent quarters, leading to a recovery and continued growth in revenues, reaching a peak near the end of the period analyzed.
The net book value of property and equipment, including right-of-use assets related to operating leases, shows consistent growth throughout the period. The asset base steadily increases quarter over quarter, demonstrating ongoing capital investment or asset accumulation. The growth rate remains relatively stable, with no significant reductions noted, indicating an expansion of fixed asset capacity over time.
The net fixed asset turnover ratio, reflecting the efficiency with which the company utilizes its fixed assets to generate revenue, starts at approximately 2.44-2.45 in late 2017 and early 2018, then declines to around 2.01-2.04 during 2020. This reduction corresponds temporally with the dip in revenue observed during the early pandemic period, suggesting less efficient use of assets at that time. From 2021 onwards, the turnover ratio shows a gradual improvement, rising to approximately 2.27 by March 31, 2022, indicating a restoration and slight enhancement of asset utilization efficiency relative to revenues.
- Revenues
- Generally increasing trend with a decline in early 2020, followed by recovery and growth.
- Property and equipment, net
- Consistent and steady growth, reflecting ongoing asset accumulation and investment.
- Net fixed asset turnover ratio
- Moderate decline during 2020 indicating reduced asset efficiency, followed by recovery and improvement through 2021 into early 2022.
Total Asset Turnover
Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||||
Total assets | ||||||||||||||||||||||||||||
Long-term Activity Ratio | ||||||||||||||||||||||||||||
Total asset turnover1 | ||||||||||||||||||||||||||||
Benchmarks | ||||||||||||||||||||||||||||
Total Asset Turnover, Competitors2 | ||||||||||||||||||||||||||||
Abbott Laboratories | ||||||||||||||||||||||||||||
CVS Health Corp. | ||||||||||||||||||||||||||||
Elevance Health Inc. | ||||||||||||||||||||||||||||
Intuitive Surgical Inc. | ||||||||||||||||||||||||||||
Medtronic PLC | ||||||||||||||||||||||||||||
UnitedHealth Group Inc. |
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).
1 Q1 2022 Calculation
Total asset turnover
= (RevenuesQ1 2022
+ RevenuesQ4 2021
+ RevenuesQ3 2021
+ RevenuesQ2 2021)
÷ Total assets
= ( + + + )
÷ =
2 Click competitor name to see calculations.
- Revenue Trends
- The revenue figures exhibit a general upward trend from March 31, 2017, through March 31, 2022. Initially, revenues increased gradually from approximately 10.6 billion USD to over 13.5 billion USD by the end of 2019. There is a notable dip in the middle of 2020, coinciding with the global disruptions of that period, where revenue dropped to around 11.1 billion USD in June 2020. Following this decline, revenues recovered substantially, reaching a peak of approximately 15.3 billion USD in December 2021 before slightly declining again to about 14.9 billion USD in the first quarter of 2022. This pattern suggests resilience and a recovery trajectory after a temporary downturn.
- Total Assets Trends
- Total assets have generally increased throughout the analyzed period. Starting at roughly 33.8 billion USD in March 2017, assets rose steadily, peaking over 51 billion USD by the third quarter of 2020. There was a minor reduction in total assets by the end of 2020, decreasing to approximately 47.5 billion USD, followed by fluctuations but maintaining an upward offset pattern. By the first quarter of 2022, total assets reached above 52 billion USD. The asset growth indicates expansion in the company’s resource base over time.
- Total Asset Turnover Ratio Patterns
- The total asset turnover ratio presents moderate fluctuations across the periods. The ratio was stable at about 1.19 to 1.21 from late 2017 through 2018, indicating consistent efficiency in using assets to generate revenue. However, starting in 2019, the ratio declined from 1.10 to a low of 1.00 in the second quarter of 2020, reflecting reduced asset efficiency, likely impacted by the challenging environment in that timeframe. Thereafter, the ratio improved steadily, climbing back to approximately 1.16 by the end of 2021 and remaining stable into early 2022. This trajectory implies a recovery in how effectively assets were deployed to produce revenues.
- Overall Insights
- The company’s financial profile indicates solid revenue growth accompanied by an expanding asset base over a five-year horizon. The dip in revenues and asset turnover efficiency during 2020 aligns with adverse external conditions, but subsequent periods show robust recovery and improved operational efficiency. The asset turnover ratio improvements alongside rising revenues suggest enhancements in asset utilization as conditions normalized.
Equity Turnover
Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||||
Stockholders’ equity (deficit) attributable to HCA Healthcare, Inc. | ||||||||||||||||||||||||||||
Long-term Activity Ratio | ||||||||||||||||||||||||||||
Equity turnover1 | ||||||||||||||||||||||||||||
Benchmarks | ||||||||||||||||||||||||||||
Equity Turnover, Competitors2 | ||||||||||||||||||||||||||||
Abbott Laboratories | ||||||||||||||||||||||||||||
CVS Health Corp. | ||||||||||||||||||||||||||||
Elevance Health Inc. | ||||||||||||||||||||||||||||
Intuitive Surgical Inc. | ||||||||||||||||||||||||||||
Medtronic PLC | ||||||||||||||||||||||||||||
UnitedHealth Group Inc. |
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).
1 Q1 2022 Calculation
Equity turnover
= (RevenuesQ1 2022
+ RevenuesQ4 2021
+ RevenuesQ3 2021
+ RevenuesQ2 2021)
÷ Stockholders’ equity (deficit) attributable to HCA Healthcare, Inc.
= ( + + + )
÷ =
2 Click competitor name to see calculations.
The quarterly financial data reveals several noteworthy trends and fluctuations over the analyzed period. Revenue shows a general upward trend with some volatility, increasing from approximately 10,623 million US dollars in the first quarter of 2017 to a peak of 15,276 million US dollars in the fourth quarter of 2021, followed by a slight decline to 14,945 million US dollars in the first quarter of 2022. Periodic fluctuations within each year suggest seasonal or operational influences on revenue generation.
Stockholders’ equity attributable to the company remains negative throughout the entire period, indicating a deficit position. However, this deficit generally decreases in magnitude from around -7,017 million US dollars in early 2017 to a less severe deficit of -2033 million US dollars by the first quarter of 2022. There are notable improvements especially during 2020 and 2021, with equity turning positive briefly in the first quarter of 2021 (572 million US dollars), before reverting back to negative territory. This suggests fluctuations in retained earnings, capital structure changes, or valuation adjustments impacting equity.
The equity turnover ratio data is sparse, with reported values only in the latter part of the timeline (notably 90.09 and 213.15), which hampers a thorough trend analysis. The spikes in this ratio indicate periods of high sales efficiency relative to the equity base, but the incomplete data limits comprehensive conclusions.
Overall, revenue growth coupled with a recovering equity position, albeit still negative, points to improving operational performance. The company appears to have faced challenges in stabilizing its equity base but demonstrates resilience in its revenue streams. The fluctuating equity turnover ratios in recent periods further suggest dynamic changes in asset utilization or capital management strategies.
- Revenues
- Exhibited a general upward trajectory from 10.6 billion to 15.3 billion US dollars with seasonal variations and a slight decline early in 2022.
- Stockholders’ Equity
- Consistently negative, but improved from a deficit of about 7 billion to approximately 2 billion negative, with a temporary positive fluctuation in early 2021.
- Equity Turnover Ratio
- Limited data prevents full analysis, though recorded values indicate high sales efficiency relative to equity in recent periods.